All News


Where have all the risk-takers gone?

European venture capitalists are no longer prepared to take any risk with their investments, undermining the biotech sector. That, anyway, is the opinion of many a frustrated biotech entrepreneur.

A new Swedish model in biotech start-ups

Who should profit from cutting-edge academic research: the scientists or the institution that funds them? Both, in a new biotech company launched by one of Sweden’s leading researchers.